WHO's 6 Regulatory Principles For AI, The Challenges Of Precision Medicine Trials, and More
Clinical Leader
A resource and forum to investigate and resolve the common struggles related to running effective clinical trials.
Welcome to the Clinical Trial Insights newsletter, featuring strategic insights and expert opinions on designing and running clinical trials. Each edition covers the latest trending articles on ClinicalLeader.com.
In this week's issue, we'll review the WHO's 6 principles for an AI regulatory framework, why e-technologies have been slow to adopt, the challenges of precision medicine trials, life science trends to watch for in 2024, and other popular insights.
If you like what you're seeing in our condensed LinkedIn editions, subscribe to our daily newsletter for full access to exclusive articles, webinars, e-books, and more! Subscribe Now →
You're Invited!
Slow the Burn Part 2: A Deeper Dive on How to Mitigate Financial Risk
January 23rd @ 11AM EST
In our previous webinar, we heard clinical operations experts talk about the importance of careful contract review when selecting an outsourcing partner. Join us tomorrow as we dive deeper into the common red flags to look for, the critical questions to ask, and best practices for safeguarding your trial’s budget.
TOP 5 READS OF THE PAST WEEK
The World Health Organization recently published a paper titled Regulatory Considerations on Artificial Intelligence for Health, identifying the key principles that international regulatory frameworks for artificial intelligence should address and are, in fact, starting to coalesce around. Sean Hilscher and Tanvi Mehta provide an overview.
Despite an abundance of "e" technologies designed to streamline various elements of the clinical trial process, many sites still rely on paper-based systems. Check out this discussion from Clinical Leader Live on some possible reasons for this conundrum and what technologies are helping and increasing in adoption.
领英推荐
As Sumitomo Pharma America, Inc. starts to focus more on precision medicine, the sponsor is encountering a new set of challenges when it comes to running clinical trials. SMPA's Chief Oncology Development officer Jatin S. sat down with Clinical Leader chief editor Dan Schell to discuss.
What are the emerging trends that could shape the life sciences industry in 2024? From AI's broad operational impact to the adoption of innovative franchise models with SaaS providers, take a look at a few trends that could define life sciences in the coming year in this infographic from ThoughtSphere .
In the world of rare diseases, where patients often feel overlooked, the FSHD Society and Fulcrum Therapeutics' partnership exemplifies the power of trust and shared commitment to patients. Ken K. and Mel Hayes share how their partnership evolved from small, meeting-oriented work to a transformative initiative.
MORE TO EXPLORE
Clinical Leader is an online community serving professionals in the clinical research space. We share insights and best practices — from industry experts — to help sponsors and CROs tackle the biggest challenges they face in designing and running clinical trials.
To get the most out of our offerings, join the Clinical Leader community.